3 High Growth Stocks With Earnings Growth Over 58%

Interest rates are climbing again as the Federal Reserve talks about “removing a dose of accommodation,” and cash parked in long-term bonds is feeling the strain. Growth-focused businesses with solid balance sheets give you a different way to seek upside if borrowing costs stay elevated. This article breaks down three companies from a high quality growth shortlist that analysts currently expect to increase earnings over the next few years.

The three stocks covered next are only a small sample of what fits this “healthy high growth potential” idea. The full screen surfaces another 285 companies that analysts currently expect to lift earnings while keeping balance sheets in reasonable shape.

If you want to identify and analyze the highest conviction fits for your own watchlist, head straight into the Healthy high growth potential screener.

Amylyx Pharmaceuticals (AMLX)

Amylyx Pharmaceuticals leans hard into the “healthy high growth potential” theme because it is almost entirely about developing future therapies, with AMX0035 and AMX0114 in neurodegenerative diseases and a growing avexitide franchise in rare endocrine disorders, all supported by a roughly US$3.5b market cap.

Amylyx Pharmaceuticals is a pre-revenue biotech where the screener story really hinges on how its late stage and early stage treatments could translate pipeline science into earnings power over the next few years.

"Advancement of avexitide as a potential first approved therapy for post bariatric hypoglycemia, supported by five prior PBH trials and a fully recruited pivotal Phase III LUCIDITY study with top line data expected in Q3 2026, could open a new rare disease revenue stream if outcomes support approval and reimbursement."

The real swing factor is how one future decision on commercial execution shapes the gap between headline growth forecasts and actual cash generation.

That execution gap is exactly what the full narrative unpacks in the full narrative for Amylyx Pharmaceuticals, including how management decisions could accelerate or stall that earnings translation.

Micron Technology (MU)

Micron Technology supplies the memory and storage chips that power cloud servers, AI accelerators, phones, PCs, and cars. Its data center DRAM and SSD lines tie it most directly to the Healthy high growth potential theme. The stock’s market value sits around US$1.21t.

"The most important question is whether the earnings power is durable enough to justify a higher valuation than investors have historically assigned to memory companies. Micron is still cyclical, but the AI cycle is larger, longer, and more contract-backed than previous memory cycles."

For investors, what happens to pricing power if a single unseen pressure on AI-related memory demand starts to ease will matter a lot.

If that pressure eases faster than expected, the full narrative for Micron Technology shows how AI demand, contract structures, and past cycle scars could reshape where Micron Technology’s earnings finally settle.

Space Exploration Technologies (SPCX)

Space Exploration Technologies blends rockets, satellite broadband, and AI platforms. The Connectivity segment ties it most directly to the Healthy high growth potential theme through Starlink’s push to scale low Earth orbit internet for households, enterprises, and governments worldwide.

Space Exploration Technologies generates US$13.9b from Connectivity, US$5.1b from AI, and US$4.1b from Space, with a market value around US$2.16t.

Space Exploration Technologies sits in this screener because Starlink’s low Earth orbit broadband is where analysts see the clearest earnings ramp. Rockets and AI infrastructure add extra optionality in very different end markets.

"Starlink satellite internet is currently the main driver of revenue and is the only division reporting an operating profit."

What happens if one key assumption about how quickly that profit engine can support the rest of the platform quietly shifts?

If that shift matters to your thesis, the full narrative for Space Exploration Technologies explains how Starlink, rockets, and AI could either accelerate or stall Space Exploration Technologies over time.

Seeking Fresh Alternatives Before They Fly

Fresh opportunities do not sit still. Breakout trends, shifting momentum, and under the radar stories can get caught by the crowd fast. Scan these curated ideas now and get in early.

• Spot established producers before momentum headlines arrive by running through the 36 elite gold producer stocks while the strongest balance sheets are still under the radar.
• Hunt for future automation leaders using the curated 89 robotics and automation stocks before industrial spending cycles are fully priced in by everyone else.
• Track energy infrastructure plays that could be central to long term capacity upgrades using the focused 40 power grid technology and infrastructure stocks while valuations still reflect hesitation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com